Active Ingredient(s): Pegaptanib
FDA Approved: * December 17, 2004
Pharm Company: * EYETECH PHARMS
Category: Vision / Eye Health

Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD).[2] It was discovered by NeXstar Pharmaceuticals (which merged with Gilead Sciences in 1999) and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Gilead Sciences continues to receive royalties from the drugs licensing. [3] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Macugen 3.47 mg/ml Intravitreal Injection, Solution
NDC: 68782-001
Eyetech Inc.

Popular Topics

macugen lucentis

masculen degeneration...